REVERSIONEX Trademark

Trademark Overview

On Thursday, December 23, 2004, a trademark application was filed for REVERSIONEX with the United States Patent and Trademark Office. The USPTO has given the REVERSIONEX trademark a serial number of 78537756. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 17, 2009. This trademark is owned by Hollis-Eden Pharmaceuticals, Inc.. The REVERSIONEX trademark is filed in the Pharmaceutical Products category with the following description:

Full line of pharmaceutical preparations for immune modulation, radiation protection, and the treatment of infectious diseases and other medical diseases and disorders
reversionex

General Information

Serial Number78537756
Word MarkREVERSIONEX
Filing DateThursday, December 23, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 17, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2006

Trademark Statements

Goods and ServicesFull line of pharmaceutical preparations for immune modulation, radiation protection, and the treatment of infectious diseases and other medical diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 6, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHollis-Eden Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameHollis-Eden Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 17, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 17, 2009ABANDONMENT - NO USE STATEMENT FILED
Wednesday, February 4, 2009EXTENSION 5 GRANTED
Sunday, January 18, 2009EXTENSION 5 FILED
Wednesday, February 4, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 21, 2009TEAS EXTENSION RECEIVED
Wednesday, July 16, 2008EXTENSION 4 GRANTED
Wednesday, July 16, 2008EXTENSION 4 FILED
Wednesday, July 16, 2008TEAS EXTENSION RECEIVED
Friday, January 18, 2008EXTENSION 3 GRANTED
Friday, January 18, 2008EXTENSION 3 FILED
Friday, January 18, 2008TEAS EXTENSION RECEIVED
Tuesday, November 20, 2007EXTENSION 2 GRANTED
Wednesday, July 18, 2007EXTENSION 2 FILED
Monday, November 12, 2007EXTENSION RECEIVED WITH TEAS PETITION
Monday, November 12, 2007PETITION TO REVIVE-GRANTED
Monday, November 12, 2007TEAS PETITION TO REVIVE RECEIVED
Monday, September 17, 2007ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 17, 2007ABANDONMENT - NO USE STATEMENT FILED
Friday, July 20, 2007TEAS EXTENSION RECEIVED
Monday, December 11, 2006EXTENSION 1 GRANTED
Monday, December 11, 2006EXTENSION 1 FILED
Monday, December 11, 2006TEAS EXTENSION RECEIVED
Tuesday, July 18, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, April 5, 2006NOTICE OF PUBLICATION
Thursday, November 3, 2005TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 26, 2005ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, September 26, 2005TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 8, 2005ASSIGNED TO LIE
Thursday, September 8, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, September 8, 2005ASSIGNED TO LIE
Friday, August 26, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 2, 2005NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2005NON-FINAL ACTION WRITTEN
Thursday, July 28, 2005ASSIGNED TO EXAMINER
Thursday, January 6, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

reversionex diseases infectious treatment other disorders medical protection radiation pharmaceutical line